Breaking News Instant updates and real-time market news.

AMRN

Amarin

$4.04

0.07 (1.76%)

09:12
01/23/18
01/23
09:12
01/23/18
09:12

Amarin shares have room to run ahead of data, says Cantor Fitzgerald

Cantor Fitzgerald analyst Louise Chen views this morning's announcement from Amarin as good news since the company is on track to report top-line results from the study before the end of Q3. Amarin this morning announced that its Reduce-It cardiovascular outcomes study has reported and documented more than 90% of the targeted 1,612 primary major adverse cardiovascular events. The analyst believes the shares have to room to run ahead of the data release. She keeps an Overweight rating on the name with a $10 price target.

AMRN Amarin
$4.04

0.07 (1.76%)

08/29/17
CANT
08/29/17
NO CHANGE
Target $10
CANT
Overweight
Cantor positive on Amarin after Novartis study results
Cantor Fitzgerald analyst Louise Chen believes the Phase 3 CANTOS study results from Novartis (NVS) support the hypothesis that a long-term drug treatment focused on an anti-inflammatory mechanism in patients with a prior heart attack and inflammatory atherosclerosis can reduce cardiovascular events. In two Phase 3 trials, Amarin's (AMRN) Vascepa affected inflammatory markers including hsCRP and Lp-PLA2 while also improving lipid biomarkers, Chen tells investors in a research note. CANTOS and other recently reported studies help to increase her confidence in a positive and commercial outcome for Amarin's REDUCE-IT trial. The analyst has an Overweight rating on the shares with a $10 price target.
12/14/17
CANT
12/14/17
NO CHANGE
Target $10
CANT
Overweight
Cantor sees Vascepa benefits driving Amarin shares higher
Research recently presented to the American Heart Association by a key opinion leader showed over-the-counter fish oil supplements may contain mercury, are high in saturated fats and sugar, and may even raise lipid levels and deplete antioxidants, Cantor Fitzgerald analyst Louise Chen wrote yesterday in a research note titled "Something Smelly about Unregulated Fish Oil Contaminants." FDA approved products, such as Amarin's Vascepa, were found to be pure and safe, Chen adds. The research reinforced her view that the "differentiation and scientific benefit" of Vascepa will drive shares of Amarin higher. The analyst kept an Overweight rating on Amarin shares with a $10 price target.
12/20/17
CANT
12/20/17
NO CHANGE
Target $10
CANT
Overweight
Cantor more confident in $10 target for Amarin after management meetings
Cantor Fitzgerald analyst Louise Chen says that after spending two days with management, she has increased confidence in her Overweight rating and $10 price target for Amarin shares. The analyst believes the company's Vascepa can help lower deaths and the cost of care for patients with high triglycerides levels without increasing LDL-C. Chen believes this is still underappreciated in Amarin shares.
01/05/18
CANT
01/05/18
NO CHANGE
Target $10
CANT
Overweight
Cantor sees Amarin as top performing stock in 2018
Cantor Fitzgerald analyst Louise Chen says Amarin's preliminary 2017 results and 2018 outlook underscore her view that the company will be one of the top performing stocks in her coverage universe this year. Revenue growth is being driven by increased prescriptions for Vascepa capsules, Chen tells investors in a research note titled "AMRN Remains One of Our Top Catches of The Year." She believes the REDUCE-IT study results in 2018 will be positive and keeps an Overweight rating on the shares with a $10 price target.

TODAY'S FREE FLY STORIES

BPOP

Popular

$48.97

1.21 (2.53%)

09:51
07/23/18
07/23
09:51
07/23/18
09:51
Hot Stocks
Popular announces $125M stock repurchase plan »

Popular announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

ROKU

Roku

$50.54

0.76 (1.53%)

, NFLX

Netflix

$358.65

-2.68 (-0.74%)

09:50
07/23/18
07/23
09:50
07/23/18
09:50
Recommendations
Roku, Netflix analyst commentary  »

Roku price target raised…

ROKU

Roku

$50.54

0.76 (1.53%)

NFLX

Netflix

$358.65

-2.68 (-0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

KR

Kroger

$28.78

0.64 (2.27%)

09:50
07/23/18
07/23
09:50
07/23/18
09:50
Options
Sweep buyers of Kroger short-term calls as shares see relative strength »

Sweep buyers of Kroger…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIYY

Barclays ETN+ FI Enhanced Global High Yield ETN Series B

$98.56

(0.00%)

09:47
07/23/18
07/23
09:47
07/23/18
09:47
Hot Stocks
Barclays ETN+ FI Enhanced Global High Yield ETN Series B falls -5.6% »

Barclays ETN+ FI Enhanced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAL

Halliburton

$42.60

-2.63 (-5.81%)

09:47
07/23/18
07/23
09:47
07/23/18
09:47
Hot Stocks
Halliburton falls -5.7% »

Halliburton is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

ITW

Illinois Tool Works

$136.81

-10.04 (-6.84%)

09:47
07/23/18
07/23
09:47
07/23/18
09:47
Hot Stocks
Illinois Tool Works falls -6.4% »

Illinois Tool Works is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

EMES

Emerge Energy

$6.99

(0.00%)

09:47
07/23/18
07/23
09:47
07/23/18
09:47
Hot Stocks
Emerge Energy rises 5.8% »

Emerge Energy is up 5.8%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

HCLP

Hi-Crush Partners

$12.90

2.05 (18.89%)

09:47
07/23/18
07/23
09:47
07/23/18
09:47
Hot Stocks
Hi-Crush Partners rises 19.8% »

Hi-Crush Partners is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

DDE

Dover Downs

$3.04

1 (49.02%)

09:47
07/23/18
07/23
09:47
07/23/18
09:47
Hot Stocks
Dover Downs rises 50.5% »

Dover Downs is up 50.5%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

BIDU

Baidu

$259.54

-0.46 (-0.18%)

09:45
07/23/18
07/23
09:45
07/23/18
09:45
Downgrade
Baidu rating change  »

Baidu downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 10

    Sep

MED

Medifast

$171.25

-0.21 (-0.12%)

09:45
07/23/18
07/23
09:45
07/23/18
09:45
Recommendations
Medifast analyst commentary  »

Medifast price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

09:45
07/23/18
07/23
09:45
07/23/18
09:45
General news
Existing Home Sales to be reported at 10:00 »

June Existing Home Sales…

AMZN

Amazon.com

$1,813.84

(0.00%)

09:43
07/23/18
07/23
09:43
07/23/18
09:43
Hot Stocks
Trump calls Washington Post an 'expensive lobbyist' for Amazon »

President Trump tweeted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 26

    Jul

  • 16

    Aug

ARWR

Arrowhead

$16.02

(0.00%)

09:41
07/23/18
07/23
09:41
07/23/18
09:41
Recommendations
Arrowhead analyst commentary  »

Arrowhead fair value…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRNC

Tronc

$16.21

(0.00%)

09:41
07/23/18
07/23
09:41
07/23/18
09:41
Periodicals
Tronc seen making 'massive' layoffs at Daily News, NY Post reports »

The Daily News, which is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCLP

Hi-Crush Partners

$10.85

(0.00%)

, HAS

Hasbro

$94.02

(0.00%)

09:40
07/23/18
07/23
09:40
07/23/18
09:40
Options
Unusually active option classes on open July 23rd »

Unusual total active…

HCLP

Hi-Crush Partners

$10.85

(0.00%)

HAS

Hasbro

$94.02

(0.00%)

DLTR

Dollar Tree

$86.45

(0.00%)

HPE

HP Enterprise

$15.47

(0.00%)

IBB

iShares Nasdaq Biotechnology Index

$118.23

(0.00%)

HAL

Halliburton

$45.23

(0.00%)

RHT

Red Hat

$147.89

(0.00%)

XLF

Financial Select Sector

$27.57

(0.00%)

BMY

Bristol-Myers

$56.71

(0.00%)

TSLA

Tesla

$313.49

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 23

    Jul

  • 01

    Aug

  • 01

    Aug

  • 01

    Aug

  • 07

    Aug

  • 08

    Aug

CHFS

CHF Solutions

$1.50

0.01 (0.67%)

09:38
07/23/18
07/23
09:38
07/23/18
09:38
Hot Stocks
CHF Solutions shares rise in early trade after VA contract circulated »

Shares of CHF Solutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DPLO

Diplomat Pharmacy

$22.35

-2.575 (-10.33%)

09:35
07/23/18
07/23
09:35
07/23/18
09:35
Recommendations
Diplomat Pharmacy analyst commentary  »

Diplomat Pharmacy recent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

09:35
07/23/18
07/23
09:35
07/23/18
09:35
General news
Oil Action: NYMEX crude »

Oil Action: NYMEX crude…

09:35
07/23/18
07/23
09:35
07/23/18
09:35
General news
U.S. existing home sales preview: »

U.S. existing home sales…

UGP

Ultrapar

$11.42

0.375 (3.40%)

09:33
07/23/18
07/23
09:33
07/23/18
09:33
Downgrade
Ultrapar rating change  »

Ultrapar downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CZZ

Cosan

$8.32

0.105 (1.28%)

09:32
07/23/18
07/23
09:32
07/23/18
09:32
Downgrade
Cosan rating change  »

Cosan downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAL

Halliburton

$45.23

0.26 (0.58%)

09:32
07/23/18
07/23
09:32
07/23/18
09:32
Hot Stocks
Breaking Hot Stocks news story on Halliburton »

Halliburton says expects…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

LPNT

LifePoint

$47.85

-0.75 (-1.54%)

, CYH

Community Health

$2.72

-0.055 (-1.99%)

09:32
07/23/18
07/23
09:32
07/23/18
09:32
Recommendations
LifePoint, Community Health, Apollo Global, HCA Healthcare analyst commentary  »

Deal activity could pick…

LPNT

LifePoint

$47.85

-0.75 (-1.54%)

CYH

Community Health

$2.72

-0.055 (-1.99%)

APO

Apollo Global

$35.39

-0.22 (-0.62%)

HCA

HCA Healthcare

$108.01

0.31 (0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 27

    Jul

  • 27

    Jul

  • 02

    Aug

  • 22

    Aug

BIDU

Baidu

$260.00

-2.32 (-0.88%)

09:31
07/23/18
07/23
09:31
07/23/18
09:31
Downgrade
Baidu rating change  »

Baidu downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 10

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.